Zentalis Pharmaceuticals
Clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics. Learn more
Launch date
Employees
Market cap
AUD356m
Enterprise valuation
AUD363m (Public information from Sep 2024)
Share price
$4.36 ZNTL
New York City New York (HQ)
Authorizing premium user...